Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. Among authors: sieper j. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study.
Baraliakos X, van der Heijde D, Sieper J, Inman RD, Kameda H, Maksymowych WP, Lagunes-Galindo I, Bu X, Wung P, Kato K, Shmagel A, Deodhar A. Baraliakos X, et al. Among authors: sieper j. Arthritis Res Ther. 2024 Nov 12;26(1):197. doi: 10.1186/s13075-024-03412-8. Arthritis Res Ther. 2024. PMID: 39533349 Clinical Trial.
Exploring complement biomarkers in suspected axial spondyloarthritis.
Mistegård CE, Troldborg A, Loft AG, Thiel S, Spiller L, Protopopov M, Rios Rodriguez V, Muche B, Rademacher J, Weber AK, Lüders S, Sieper J, Poddubnyy D, Proft F. Mistegård CE, et al. Among authors: sieper j. RMD Open. 2024 May 15;10(2):e004127. doi: 10.1136/rmdopen-2024-004127. RMD Open. 2024. PMID: 38749532 Free PMC article.
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs.
Al Mohamad F, Rios Rodriguez V, Haibel H, Protopopov M, Rademacher J, Sieper J, Torgutalp M, Käding H, Proft F, Poddubnyy D. Al Mohamad F, et al. Among authors: sieper j. RMD Open. 2024 Feb 15;10(1):e004009. doi: 10.1136/rmdopen-2023-004009. RMD Open. 2024. PMID: 38360039 Free PMC article.
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial.
Proft F, Torgutalp M, Muche B, Rios Rodriguez V, Listing J, Protopopov M, Rademacher J, Haibel H, Spiller L, Weber AK, Verba M, Brandt-Juergens J, Kiltz U, Sieburg M, Jacki S, Sieper J, Poddubnyy D. Proft F, et al. Among authors: sieper j. Ann Rheum Dis. 2024 Apr 11;83(5):599-607. doi: 10.1136/ard-2023-224699. Ann Rheum Dis. 2024. PMID: 38228361 Free PMC article. Clinical Trial.
643 results